Abstract:Background To assess the differences across continental regions in terms of stroke imaging obtained for making acute revascularization therapy decisions, and to identify obstacles to participating in randomized trials involving multimodal imaging. Methods STroke Imaging Repository (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging circulated an online survey through its website, through the websites of national professional societies from multiple countries as well as through email distribution lists from STIR and the above mentioned societies. Results We received responses from 223 centers (2 from Africa, 38 from Asia, 10 from Australia, 101 from Europe, 4 from Middle East, 55 from North America, 13 from South America). In combination, the sites surveyed administered acute revascularization therapy to a total of 25 326 acute stroke patients in 2012. Seventy-three percent of these patients received intravenous (IV) tissue plasminogen activator (tPA), and 27%, endovascular therapy. Vascular imaging was routinely obtained in 79% (152/193) of sites for endovascular therapy decisions, and also as part of standard IV tPA treatment decisions at 46% (92/198) of sites. Modality, availability and use of acute vascular and perfusion imaging before revascularization varied substantially between geographical areas. The main obstacles to participate in randomized trials involving multimodal imaging included: mainly insufficient research support and staff (50%, 79/158) and infrequent use of multimodal imaging (27%, 43/158). Conclusion There were significant variations among sites and geographical areas in terms of stroke imaging work-up used to make decisions both for intravenous and endovascular revascularization. Clinical trials using advanced imaging as a selection tool for acute revascularization therapy should address the need for additional resources and technical support, and take into consideration the lack of routine use of such techniques in trial planning.

Imaging in acute ischaemic stroke: assessing findings in light of evolving therapies

Imaging Markers in Acute Phase of Stroke: Implications for Prognosis

From “Time is Brain” to “Imaging is Brain”: A Paradigm Shift in the Management of Acute Ischemic Stroke

Brain Imaging for Stroke

Neuroimaging of Acute Ischemic Stroke: Multimodal Imaging Approach for Acute Endovascular Therapy

Advanced Imaging for Acute Stroke Treatment Selection: CT, CTA, CT Perfusion, and MR Imaging

recent advances in imaging of acute ischemic stroke

Advanced Neuroimaging in Stroke Patients: Prediction of Tissue Fate and Hemorrhagic Transformation

Advances In Imaging Acute Ischemic Stroke: Evaluation Before Thrombectomy

International Survey of Acute Stroke Imaging Used to Make Revascularization Treatment Decisions

Imaging in Acute Anterior Circulation Ischemic Stroke: Current and Future

Abstract Number ‐ 247: Multimodal imaging approach for the diagnosis of (ICAD): basic principles, current and future perspectives

Acute Ischemic Stroke: Overview of Recent Therapeutic Developments

Imaging Biomarkers for Intra-arterial Stroke Therapy

Current State of Evidence for Neuroimaging Paradigms in Management of Acute Ischemic Stroke

Priorities for Advancements in Neuroimaging in the Diagnostic Workup of Acute Stroke

Imaging Acute Stroke: from One-Size-Fit-All to Biomarkers.

Imaging in Neurointerventional Stroke Treatment: Review of the Recent Trials and What Your Neurointerventionalist Wants to Know from Emergency Radiologists

From Mechanisms to Therapeutic Approaches

Detection, Diagnosis and Treatment of Acute Ischemic Stroke: Current and Future Perspectives

Automatic triaging of acute ischemic stroke patients for reperfusion therapies using Artificial Intelligence methods and multiple MRI features: A review